Electroconvulsive Therapy: Clinical Trials

5 trials of Electroconvulsive Therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 33Completed 3
Phase 11Completed 1

Follow Electroconvulsive Therapy: new trials by email Literature Review of Electroconvulsive Therapy trials Research Report on Electroconvulsive Therapy

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Electro-Magnetic Convulsive Therapies for Depression: a Non-inferiority Study
Magnetic Seizure Therapy, Electroconvulsive Therapy - Major Depressive Disorder, Bipolar Depression
Phase 2 / Phase 3CompletedUniversity of Sao Paulo1002021-05-312026-09-29
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
electroconvulsive therapy (ECT), Ketamine - Treatment Resistant Depression, Electroconvulsive Therapy
Phase 2 / Phase 3CompletedBo Hu4032017-04-072023-09-28
Retinal Imaging in CNTF -Releasing Encapsulated Cell Implant Treated Patients for Early-stage Retinitis Pigmentosa
NT-501, Sham - Retinitis Pigmentosa, Usher Syndrome Type 2
Phase 2CompletedNeurotech Pharmaceuticals222012-01-012023-02-14
The Antidepressant Effect of Repetitive Transcranial Magnetic Stimulation (rTMS)Compared to ECT
Right prefrontal lowfrequency ( 1 hz) rTMS., Electroconvulsive therapy (ECT) - Depressive Disorder
Phase 2 / Phase 3CompletedUniversity of Aarhus602002-05-012008-07-02
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
Electroconvulsive Therapy (ECT), Clozapine - Schizophrenia
Phase 1 / Phase 2CompletedNorthwell Health392000-12-012017-05-15

Conditions studied

Depression (2)  ·  Depressive Disorder (2)  ·  Depressive Disorder, Major (2)  ·  Bipolar Disorder (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mental Disorders (1)  ·  Retinitis Pigmentosa (1)  ·  Schizophrenia (1)  ·  Usher Syndromes (1)

Sponsors

Bo Hu (1)  ·  Neurotech Pharmaceuticals (1)  ·  Northwell Health (1)  ·  University of Aarhus (1)  ·  University of Sao Paulo (1)

Countries

United States (3)  ·  Brazil (1)  ·  Denmark (1)

Top investigators

Amit Anand, MD (1)  ·  Georgios Petrides, MD (1)  ·  Jacque Duncan, MD (1)  ·  Poul Erik Buchholtz Hansen, senior phys. (1)

Results publications

PMID 20351570, PMID 30572160, PMID 35900079, PMID 37224232, PMID 40900112

NIH funding

R01MH060390 (1)